NCT06976476 2026-03-11
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Clinical Trials
7 trialsNCT00967785 2026-03-09
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
National Institutes of Health Clinical Center (CC)
Phase 1/2 Recruiting
NCT05645107 2025-12-16
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Grifols Therapeutics LLC
Phase 3 Recruiting
NCT05678621 2024-04-19
RATIONALISE
Monash University
Phase 2/3 Recruiting
NCT02231879 2023-04-07
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
National Institutes of Health Clinical Center (CC)
Phase 2/3 Completed
NCT01002755 2019-05-07
Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03087370 2018-12-07
A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome
X4 Pharmaceuticals
Withdrawn